+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pruritus Therapeutics Market - Global Forecast 2026-2032- Product Image
Pruritus Therapeutics Market - Global Forecast 2026-2032- Product Image
New

Pruritus Therapeutics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888867
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pruritus Therapeutics Market is undergoing significant transformation, presenting strategic opportunities for stakeholders seeking to navigate evolving clinical and commercial landscapes. Senior decision-makers face mounting complexity in this field as innovations extend beyond traditional symptomatic treatments toward targeted, evidence-driven solutions.

Market Snapshot

The global Pruritus Therapeutics Market grew from USD 6.24 billion in 2025 to USD 6.57 billion in 2026. With a projected CAGR of 6.16%, it is expected to reach USD 9.49 billion by 2032. This growth is driven by advances in immunology, neurosensory biology, new therapeutic pathways, and changing regulatory and reimbursement environments.

Scope & Segmentation

This report offers a comprehensive analysis of emerging trends, operational challenges, and commercial opportunities across all major segments:

  • Therapeutic Classes: Includes antihistamines, biologics, calcineurin inhibitors, corticosteroids, and immunosuppressants, each with distinct mechanisms, clinical applications, and safety considerations.
  • Administration Routes: Analysis of injectable, oral, and topical delivery, addressing patient adherence, convenience, systemic exposure, and required monitoring.
  • Disease Indications: Covers allergic contact dermatitis, atopic dermatitis, cutaneous T-cell lymphomas, and urticaria, each shaping diagnostic and treatment strategies.
  • Patient Demographics: Differentiates approaches for adult, geriatric, and pediatric populations, with attention to dosing, safety oversight, and comorbidity management.
  • Distribution Channels: Evaluates hospital, online, and retail pharmacy models, assessing inventory, reimbursement integration, and patient support infrastructures.
  • Care Settings: Tracks therapy initiation and escalation in clinics, dermatology centers, hospitals, and homecare environments.
  • Regions: Delivers insights covering the Americas, EMEA (Europe, Middle East, and Africa), and Asia-Pacific, highlighting region-specific clinical, regulatory, and commercial factors.
  • Technologies: Examines digital health, telemedicine, biologics platforms, new drug delivery systems, and patient support innovations impacting engagement and outcomes.

Key Takeaways

  • New biological insights are enabling precision approaches, moving away from generalist management of pruritus.
  • Mechanism-specific therapies are being adopted more widely, in parallel with digital health solutions that allow early intervention and robust monitoring.
  • Regulatory authorities are increasingly valuing patient-reported outcomes and real-world evidence in both approval and reimbursement processes.
  • Commercial models are adjusting to include outcomes-based pricing, streamlined distribution partnerships, and advanced patient support systems.
  • Segmentation by indication, demographic, and care setting is vital to identify highest unmet needs and refine commercial targeting.
  • Incumbents and innovators alike are leveraging clinical partnerships, digital integrations, and real-world data to differentiate offerings and shape adoption pathways.

Tariff Impact

Recent tariff changes have directly impacted the Pruritus Therapeutics Market, influencing supply chain and operational strategies. Companies are diversifying supplier bases and investing in domestic manufacturing to ensure resilient, cost-effective delivery. Procurement strategies now focus on greater transparency, renegotiation of contracts, and closer attention to duty and compliance costs, which directly affect pricing and viability in highly competitive product segments. Strategic partnerships and adaptable inventory models are emerging as practical responses to shifting trade environments, supporting business continuity and margin optimization.

Methodology & Data Sources

This analysis combines primary expert interviews with supply chain leaders, clinicians, and payer advisors, together with systematic reviews of peer-reviewed studies, regulatory filings, and company records. Findings are validated through real-world evidence and cross-checked using established assessment frameworks and documented analytical decisions to ensure transparency and reproducibility.

Why This Report Matters

  • Enables executive teams to align product development, commercial, and operational strategies with evolving stakeholder requirements and payer expectations.
  • Assists leadership in identifying where investment in supply chain, digital engagement, and clinical partnerships will drive measurable impact and competitive differentiation.
  • Delivers actionable market intelligence and a segmentation framework to inform pragmatic prioritization and risk management in global and regional market launches.

Conclusion

The Pruritus Therapeutics Market demands a strategic blend of innovation, operational agility, and evidence-led commercial execution. Organizations that proactively adapt to these shifts will achieve sustained access and growth in a rapidly evolving treatment ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pruritus Therapeutics Market, by Therapy
8.1. Antihistamines
8.2. Biologics
8.3. Calcineurin inhibitors
8.4. Corticosteroids
8.5. Immunosuppressant
9. Pruritus Therapeutics Market, by Route of Administration
9.1. Injectable
9.2. Oral
9.3. Topical
10. Pruritus Therapeutics Market, by Disease Indication
10.1. Allergic Contact Dermatitis
10.2. Atopic Dermatitis
10.3. Cutaneous T-cell
10.4. Urticaria
11. Pruritus Therapeutics Market, by Patient Demographics
11.1. Adult Patients
11.2. Geriatric Patients
11.3. Pediatric Patients
12. Pruritus Therapeutics Market, by Distribution Channel
12.1. Hospital Pharmacies
12.2. Online Pharmacies
12.3. Retail Pharmacies
13. Pruritus Therapeutics Market, by End-User
13.1. Clinics
13.2. Dermatology Centers
13.3. Homecare Settings
13.4. Hospitals
14. Pruritus Therapeutics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Pruritus Therapeutics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Pruritus Therapeutics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Pruritus Therapeutics Market
18. China Pruritus Therapeutics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. Asana BioSciences, LLC
19.7. Astellas Pharma Inc.
19.8. Avior Bio Inc.
19.9. Bausch Health Companies Inc.
19.10. Bayer AG
19.11. Cara Therapeutics Inc.
19.12. Eli Lilly and Company
19.13. EPI Health LLC by Novan, Inc.
19.14. Escient Pharmaceuticals by Incyte Corporation
19.15. Evelo Biosciences, Inc.
19.16. Galderma S.A.
19.17. GlaxoSmithKline plc
19.18. LEO Pharma A/S
19.19. Mallinckrodt plc
19.20. MC2 Therapeutics A/S
19.21. Mirum Pharmaceuticals, Inc.
19.22. NeRRe Therapeutics Ltd
19.23. Novartis AG
19.24. Pfizer Inc.
19.25. Regeneron Pharmaceuticals, Inc.
19.26. Sanofi S.A.
19.27. Teva Pharmaceutical Industries Ltd.
19.28. Toray Industries, Inc.
19.29. Trevi Therapeutics, Inc
19.30. Vanda Pharmaceuticals Inc.
19.31. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PRURITUS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PRURITUS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA PRURITUS THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ANTIHISTAMINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY IMMUNOSUPPRESSANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY IMMUNOSUPPRESSANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY IMMUNOSUPPRESSANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ALLERGIC CONTACT DERMATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ALLERGIC CONTACT DERMATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ALLERGIC CONTACT DERMATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CUTANEOUS T-CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CUTANEOUS T-CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CUTANEOUS T-CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY URTICARIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY URTICARIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY URTICARIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ADULT PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ADULT PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY GERIATRIC PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY GERIATRIC PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PEDIATRIC PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY PEDIATRIC PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DERMATOLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DERMATOLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY DERMATOLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. EUROPE PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 105. EUROPE PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. EUROPE PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 107. EUROPE PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 108. EUROPE PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. EUROPE PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 117. AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 119. AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 120. AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 121. AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 122. AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. AFRICA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 126. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 128. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 134. ASEAN PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 135. ASEAN PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 136. ASEAN PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 137. ASEAN PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. ASEAN PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 139. GCC PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GCC PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 141. GCC PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 142. GCC PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 143. GCC PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 144. GCC PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. GCC PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 153. BRICS PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. BRICS PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 155. BRICS PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 156. BRICS PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 157. BRICS PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 158. BRICS PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. BRICS PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 160. G7 PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. G7 PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 162. G7 PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. G7 PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 164. G7 PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 165. G7 PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. G7 PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 167. NATO PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. NATO PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 169. NATO PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. NATO PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 171. NATO PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 172. NATO PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. NATO PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL PRURITUS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 182. CHINA PRURITUS THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 183. CHINA PRURITUS THERAPEUTICS MARKET SIZE, BY THERAPY, 2018-2032 (USD MILLION)
TABLE 184. CHINA PRURITUS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. CHINA PRURITUS THERAPEUTICS MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 186. CHINA PRURITUS THERAPEUTICS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD MILLION)
TABLE 187. CHINA PRURITUS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. CHINA PRURITUS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Pruritus Therapeutics market report include:
  • AbbVie Inc.
  • Asana BioSciences, LLC
  • Astellas Pharma Inc.
  • Avior Bio Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cara Therapeutics Inc.
  • Eli Lilly and Company
  • EPI Health LLC by Novan, Inc.
  • Escient Pharmaceuticals by Incyte Corporation
  • Evelo Biosciences, Inc.
  • Galderma S.A.
  • GlaxoSmithKline plc
  • LEO Pharma A/S
  • Mallinckrodt plc
  • MC2 Therapeutics A/S
  • Mirum Pharmaceuticals, Inc.
  • NeRRe Therapeutics Ltd
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Toray Industries, Inc.
  • Trevi Therapeutics, Inc
  • Vanda Pharmaceuticals Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.57 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.49 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Pruritus Therapeutics Market Report 2025 - Product Image

Pruritus Therapeutics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report - Product Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Pruritus Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Pruritus Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 132 Pages
  • Global
From
Cholestatic Pruritus Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035 - Product Image

Cholestatic Pruritus Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Pruritus Therapeutics Market Size, Share & Trends Analysis Report by Disease (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), Product (Corticosteroids, Antihistamines), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Pruritus Therapeutics Market Size, Share & Trends Analysis Report by Disease (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria), Product (Corticosteroids, Antihistamines), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From

About the Pruritus Drug Market

Pruritus, or itching, is a common symptom of many skin conditions and can be treated with dermatological drugs. These drugs are typically divided into two categories: topical and systemic. Topical drugs are applied directly to the skin and can include corticosteroids, calcineurin inhibitors, and antihistamines. Systemic drugs are taken orally or injected and can include anticonvulsants, antidepressants, and opioids. The pruritus drug market is a subset of the larger dermatological drug market. It is composed of a variety of drugs used to treat itching, including both topical and systemic treatments. These drugs are used to treat a wide range of skin conditions, from eczema and psoriasis to allergic reactions and insect bites. Some companies in the pruritus drug market include Pfizer, Novartis, GlaxoSmithKline, Sanofi, and Merck. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.